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to mildly raised blood pressure and that retinopathy is a close correlate of this risk [6] .
von Willebrand factor (vWF) is synthesised by vascular endothelial cells and megakaryocytes and an increased concentration in plasma can serve as a marker of endothelial cell damage [7] [8] [9] . Such an increase is a feature of diabetic nephropathy [10] . Recent studies in small numbers of subjects with IDDM suggest that vWF is a sensitive marker of incipient nephropathy and that a rise in the plasma concentration may even precede the development of microalbuminuria [11, 12] . Information regarding any relationship between vWF and retinopathy is, however, conflicting [13] [14] [15] . vWF is an essential component in platelet adhesion to subendothelium and a potential role in the pathogenesis of diabetic microvascular disease cannot be discounted [7] .
Several epidemiological studies have confirmed the role of plasma fibrinogen as an independent risk factor for myocardial infarction and stroke in the general population [16] [17] [18] . Although microalbuminuria in diabetes predicts for an increased risk of cardiovascular death [19] [20] [21] , the relationships between fibrinogen and microalbuminuria have only been studied in a limited number of subjects [22, 23] . In addition, while complex interrelationships between plasma fibrinogen concentration and lifestyle and lipid riskfactors have been identified in population studies [24] [25] [26] [27] , these surveys included few IDDM patients.
The EURODIAB IDDM Complications Study is a cross-sectional clinic-based study of complications in randomly selected IDDM patients attending 31 clinics in 16 European countries which was established to measure the prevalence and severity of diabetic complications and to examine specific relations between putative risk factors [3] . In order to explore the potentially important interrelationships between a vascular risk factor for macrovascular disease, and a marker of endothelial cell damage, and complications in subjects with IDDM, we have included assays for plasma fibrinogen and vWF in the study programme.
Subjects and methods
Details of patient selection have been previously described (Eurodiab IDDM Complications Study Group, 1994) . In summary, each centre selected a stratified random sample of patients attending the hospital in 1 year. IDDM was defined as onset before age 36 years with continuous insulin treatment initiated less than 1 year from diagnosis. From the entire study cohort of 3250 patients blood samples for analysis of haemostatic and lipid risk factors were available on 2091 (64 %). The demographic and clinical characteristics are listed in Table 1 . The composition of the study group was representative of the entire cohort, there being no significant difference in any of the parameters listed. All centres were represented.
Albumin excretion rate (AER) was determined, from a timed 24-h urinary collection after exclusion of urinary infection, in a central laboratory by an immunoturbidometric method using goat anti-human albumin antiserum and human serum albumin standards. Microalbuminuria was defined as AER between 20 and 200 m g/min. HbA 1 c was measured in a central laboratory by immunoassay using monoclonal antiHbA 1 c . Plasma fibrinogen and vWF were also measured centrally on citrated plasma prepared from fresh blood obtained by venepuncture. Plasma samples were stored at less than -20 degrees C°at all times until assay. Fibrinogen was assayed by a clotting assay based on the prothrombin time, on an Instrumentation Laboratories Series 300(R) Autoanalyser and vWF antigen by ELISA, as previously described [28] ; a pooled plasma standard, calibrated against the UK (NIBSAC) standard, was employed. Hidden duplicate samples were included as a check on reproducibility. Satisfactory performance of these assays in UK National Quality Assurance schemes was recorded. Triglyceride, cholesterol and the cholesterol content of HDL were determined on fasting serum, after manganese and heparin precipitation, by standard enzymatic techniques; LDL cholesterol was calculated.
Presence of cardiovascular disease (CVD) was assessed by the clinical history of myocardial infarction, angina pectoris, stroke or coronary artery bypass graft surgery, and by Minnesota-coding of 12-lead resting ECGs [29] . Sitting blood pressure was measured to the nearest 2 mmHg. with a random zero sphygmomanometer after 5 min of rest; the mean of two readings was used for analysis. Retinopathy was assessed from photographs of two retinal fields per eye graded by a single observer, as previously described [30] .
Statistical analysis
To examine the association of fibrinogen and vWF with other risk factors for diabetes complications and also with the diabetes complications themselves, for each variable, analysis of covariance was used, to calculated age and HbA 1 c adjusted mean levels of the haemostatic variables within each category, and the adjusted means were compared across categories. For continuous variables these categories were defined using the (10) 103 (10) quartiles of the distribution for the variable, with the exception of age where the stratification implemented in the selection of the EURODIAB sample was used [3] . Analysis of variance was also used to assess the significance of the interaction of retinopathy with fibrinogen and vWF. For any analyses that included vWF, albumin excretion and fasting triglyceride as continuums, because of the skewness of their distributions, the variables were logged and geometric means quoted.
Results
The expected strong relationships between age and both fibrinogen and vWF were confirmed, although this was confined to males in the case of fibrinogen (Table 2) . Plasma fibrinogen and vWF, adjusted for age, were also strongly related to glycaemic control and fibrinogen rose with increasing body mass index (BMI; Table 2 ). Compared with non-smokers, ageand HbA 1 c -adjusted mean fibrinogen was significantly higher in current smokers for both genders and only in men higher in ex-smokers (Table 3) . No such relationships were found in the case of vWF. A relationship was apparent between both systolic and diastolic blood pressure and adjusted fibrinogen, but not vWF, concentrations (Table 3) . Although the prevalence of CVD was highest in the quartile with highest adjusted fibrinogen values in both males and females the trend did not achieve statistical Table 4 ; it is apparent that a higher level of total cholesterol and lower level of HDL cholesterol is accompanied by a higher fibrinogen concentration in males. Fibrinogen is significantly related to LDL cholesterol in females. There is also a positive relationship between fibrinogen and triglyceride in both genders. vWF is only weakly related to lipid parameters, being significantly related to fasting triglyceride in males only. Higher concentrations of adjusted fibrinogen were found in males and females with neuropathy, and of vWF in females with this complication (Table 5) .
There was no difference in haemostatic measures between those with microalbuminuria and those with normoalbuminuria, but subjects with AER of more than 200 m g/min had significantly higher plasma fibrinogen and vWF (Table 5) . A marked interaction was apparent across the range of AER values with both vWF and fibrinogen in the group with retinopathy, which was not apparent in those without this complication (Fig. 1) .
Discussion
In this extensive study of subjects with IDDM we have found relationships between plasma fibrinogen concentration and age, body mass index, and smoking habit which are comparable to those described in the general population [24] [25] [26] [27] . In addition there appears to be a clustering of vascular risk factors, including raised fibrinogen, total and LDL cholesterol, triglyceride and blood pressure and reduced HDL cholesterol, in IDDM. Comparable relationships between lipid risk factors and fibrinogen have been reported in hyperlipidaemia [31] and similar findings described in cross-sectional studies in the general population [25] . Although the underlying mechanism remains unexplained, a role for non-esterified fatty acids in hepatic fibrinogen synthesis has been postulated [32] , and we have reported a correlation between plasma concentrations of Apo A1 and fibrinogen in IDDM [33] . Despite this clustering of risk factors no significant relationship was found between fibrinogen and symptomatic and electrocardiographic evidence of CVD in this diabetic population. This is probably due to the relatively imprecise methods employed for assessment of the presence of atheromatous disease [29] and it is likely that the follow-up study, in which death and non-fatal myocardial infarction are used as end-points, will clarify any relationship.
In view of previous studies indicating that, in IDDM, those who develop clinical proteinuria have a much increased risk of premature cardiovascular complications [34, 35] we were interested to study the relationships between albuminuria and vWF, a marker of vascular endothelial cell damage. Injury to the vascular endothelium appears to be central to the pathogenesis of atherosclerosis and may be an initiating event. Endothelial dysfunction is also a feature of diabetic nephropathy, even during the subclinical phase. Evidence for this includes the observation that the transcapillary escape rate of albumin is increased [36] , and vasoconstrictor responses are blunted [37] in diabetic subjects with albuminuria. In addition the plasma concentrations of several peptides and proteins which are secreted by vascular endothelium, including plasminogen activator inhibitor (PAI) 1 [38] endothelin [39] and vWF [11] have been found to be increased in the presence of microalbuminuria. Indeed Stehouwer et al. [12] reported that, in six subjects, the increase in plasma vWF preceded and may therefore predict the development of microalbuminuria in IDDM. Clinical proteinuria without retinopathy is uncommon, but severe retinopathy with normal AER is a frequent finding in IDDM [6] , suggesting that different pathogenetic mechanisms may be operating; it is noteworthy that data on plasma vWF in retinopathy are conflicting [14, 15] .The results of the current study of over 2000 carefully clinically characterised subjects demonstrate a strong interaction between AER and vWF only in those with retinopathy, this being highly reminiscent of the relationships between blood pressure, AER and retinopathy in the same population [6] . There was, however, only a weak, or no, significant direct relationship between vWF and blood pressure. A plausible interpretation of these data is that, in the subgroup of patients who develop nephropathy in association with an increased renal vulnerability to modest increases in blood pressure, the renal vasculopathy is mediated through endothelial damage, and this is The interaction of retinopathy with fibrinogen and von Willebrand factor gave a significance of p < 0.001 in both cases consistent with the hypothesis that microalbuminuria and release of vWF are responses to mildly raised blood pressure in subjects with retinopathy. Although those patients with clinical nephropathy had significantly higher plasma vWF concentrations than those with no albuminuria we were unable to confirm a similar increased level in association with microalbuminuria, a finding consistent with some [10] , but not other [11] , smaller studies. The patients enrolled in the EURODIAB Study are likely to be more representative of the overall diabetic population than has been the case in some more limited investigations, and the possible predictive value of vWF measurement will be better determined from follow-up data which will accrue after 5 years from recruitment.
There was also a marked interaction between fibrinogen and AER in diabetic patients with retinopathy which persisted after adjustment for confounding variables. It has long been recognised that plasma fibrinogen concentration is elevated in diabetes [40] but a relationship with nephropathy has not always been apparent [41] . Fibrinogen could contribute to the development of nephropathy in a variety of ways: it is the substrate for thrombin in blood coagulation, and animal studies indicate that the fibrinogen concentration at the initiation of coagulation influences the amount of fibrin deposited [42] ; in this context it is relevant that low-dose heparin therapy was recently shown to reduce urinary albumin excretion rate in IDDM [43] . Fibrinogen is also an essential cofactor in platelet activation, and aggregability is influenced by the fibrinogen concentration in plasma [44] . Involvement of platelets and blood hypercoagulability in the pathogenesis of diabetic nephropathy has been postulated [45, 46] . An alteration in glomerular haemodynamics has long been considered to be of pathophysiological importance in diabetic nephropathy and therefore the contribution of fibrinogen to the viscosity of blood may be of relevance. Furthermore, LDL cholesterol makes an equivalent contribution to viscosity [47] and our data indicate that this is also increased in the plasma of diabetic subjects, in close parallel with fibrinogen. In IDDM blood viscosity is higher in those with microvascular complications than in those without [33] , and, in a morphological study of human diabetic neuropathy, which may also have a microvascular pathogenesis [48, 49] , we previously demonstrated a strong association between plasma fibrinogen concentration and sural nerve capillary basement membrane thickness [28] . In the current study fibrinogen levels were also significantly higher in diabetic patients with neuropathy. It is noteworthy that renal and nerve damage have been found to be associated in diabetes [50] . Our finding of higher levels of vWF in females with diabetic neuropathy is also of interest, in view of the recent suggestion that plasma vWF concentration predicts progression of neuropathy in IDDM [51] .
While changes in fibrinogen and vWF may not be causal in the vascular damage of diabetic microangiopathy, they could contribute through their effects on platelets, coagulability and viscosity, forming part of a self-propagating series of events leading to further endothelial damage and dysfunction. Although both fibrinogen and vWF are acute phase response proteins, this would not necessarily preclude a pathogenetic role in diabetic microvascular disease, for the above reasons, and as an explanation for the increased levels this mechanism is inconsistent with previous observations, where plasma C-reactive protein and vWF were not related in diabetes [14] , nor in the vasculitides [52] . Regarding fibrinogen, the interrelationships with lipid parameters in the current and previous studies have not been linked to a reactive state, although recent data do suggest an association between lipid vascular risk factors, fibrinogen and C-reactive protein [53] . Restriction length polymorphisms which are associated with variation in fibrinogen levels have been identified [54] although the size of the genetic contribution to fibrinogen level is unclear. As there is evidence for a genetic predisposition to the development of diabetic nephropathy [55, 56] , it is of interest to speculate that this may operate through fibrinogen or, perhaps, vWF.
The findings reported here support the hypothesis of a role for fibrinogen and vWF in vascular complications of IDDM and provide the basis for a valuable prospective follow-up study which will indicate the predictive value of fibrinogen and vWF in the development of CVD and other complications in diabetes.
